Gamida Cell Ltd(NASDAQ:GMDA) 
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company's lead product candidate is omidubicel, a cell therapy that is in Phase III studies in patients with high-risk hematologic malignancies, as well as in P...
Website: http://www.gamida-cell.com
Founded: 1998
Full Time Employees: 79
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-11-03
P
O 0.69
H 0.80
L 0.68
C 0.79
V 1,317,155
10EMA 0.79
20EMA 0.79
60EMA 0.79
120EMA 0.79
250EMA 0.79